Facebook Tracking Image

National Comprehensive Cancer Network

Members Only
NCCN Oncology Research Program (ORP)
NCCN Puma Neratinib Research Grant Opportunity: submit by Monday, April 19, 2021
Study Proposal Submission-NCCN iEnvision
NCCN AstraZeneca NSCLC Research Opportunity: submit LOIs by Monday, May 3, 2021
ORP Recent News
ORP Scientific Publications
ORP for Industry
ORP Investigator Steering Committee
ORP Testimonials
Clinical Trials at NCCN Member Institutions
Find NCCN ORP Funded Clinical Trials at NCCN Member Institutions
ORP Grant History
Informed Consent Language Database
Points to Consider on the Best Practices for Biorepositories, Registries and Databases
NCCN Shared Resources
ORP Disclosure Policy
NCCN Collaboration with the National Business Group on Health
NCCN Health Information Technology Licensees
NCCN Policy Priorities

NCCN Research & Business Resources

Research Platforms & Services

Investigator Initiated Research Grant Model
This model uses a peer-review process to evaluate and approve proposals for investigator initiated research using either investigational or commercially available cancer drugs. 

Protocol Development Model
The NCCN ORP organizes a Protocol Development Team to work with industry collaborators to identify their research needs and subsequently design and implement a protocol.

Quality Improvement Collaboration Model
Quality improvement, outcomes, or educational projects are solicited from NCCN Member Institutions or health care organizations across the country.

Multi-Industry Collaboration Model 
The NCCN ORP is able to establish a research collaboration with multiple companies in a comprehensive agreement.  Such agreements allow NCCN Member Institutions and companies to collaborate on novel combinations of particular scientific interest.